Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib and Irinotecan in High-Risk Neuroblastoma
NCT00135135Phase 2Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Aug 2005
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gefitinib in neuroblastoma, sponsored by St. Jude Children's Research Hospital. Primary endpoint: Response Rate. Started Aug 2005; status: completed.
02
Drugs
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00135135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00135135.